BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 1630665)

  • 1. [Diabetic cardiomyopathy: possible pathogenetic role of coronary microcirculation].
    Martinez R
    Minerva Cardioangiol; 1992; 40(1-2):1-5. PubMed ID: 1630665
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Myocardial and coronary vessel dysfunction in diabetes I patients].
    Konduracka E; Galicka-Latała D; Piwowarska W; Sieradzki J
    Przegl Lek; 2002; 59(7):514-8. PubMed ID: 12516240
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Diabetic cardiomyopathy: concept, heart function, and pathogenesis].
    Codinach Huix P; Freixa Pamias R
    An Med Interna; 2002 Jun; 19(6):313-20. PubMed ID: 12152393
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Myocardial disease in diabetes mellitus].
    Gullestad L; Kjekshus J
    Tidsskr Nor Laegeforen; 1992 Mar; 112(8):1016-9. PubMed ID: 1553723
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Diabetic cardiomyopathy].
    Cohen A
    Arch Mal Coeur Vaiss; 1995 Apr; 88(4):479-86. PubMed ID: 7646266
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [New pathogenetic mechanisms of idiopathic dilated cardiomyopathy: changes in coronary microcirculation].
    Neglia D
    Recenti Prog Med; 2003 Jun; 94(6):247-52. PubMed ID: 12793095
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diastolic dysfunction and abnormalities of the microcirculation in type 2 diabetes.
    Brooks BA; Franjic B; Ban CR; Swaraj K; Yue DK; Celermajer DS; Twigg SM
    Diabetes Obes Metab; 2008 Sep; 10(9):739-46. PubMed ID: 17941867
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Progressive attenuation of myocardial vascular endothelial growth factor expression is a seminal event in diabetic cardiomyopathy: restoration of microvascular homeostasis and recovery of cardiac function in diabetic cardiomyopathy after replenishment of local vascular endothelial growth factor.
    Yoon YS; Uchida S; Masuo O; Cejna M; Park JS; Gwon HC; Kirchmair R; Bahlman F; Walter D; Curry C; Hanley A; Isner JM; Losordo DW
    Circulation; 2005 Apr; 111(16):2073-85. PubMed ID: 15851615
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inflammatory dilated cardiomyopathy (DCMI).
    Maisch B; Richter A; Sandmöller A; Portig I; Pankuweit S;
    Herz; 2005 Sep; 30(6):535-44. PubMed ID: 16170686
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Etiopathogenesis of dilated cardiomyopathies].
    Petronio AS; Manes MT; Di Meco F; Nardini V; Pecori F; Ceccherini-Nellis L; Barsotti A; Mariani M
    Cardiologia; 1993 Dec; 38(12 Suppl 1):267-76. PubMed ID: 8020025
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Suppression of nitrative damage by metallothionein in diabetic heart contributes to the prevention of cardiomyopathy.
    Cai L
    Free Radic Biol Med; 2006 Sep; 41(6):851-61. PubMed ID: 16934665
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Coronary atherosclerosis or diabetic cardiomyopathy? Pathoanatomic changes of blood vessels, nerves and myocardium in patients with diabetes mellitus].
    Melchior TM; Seibaek MB; Sajadieh A
    Ugeskr Laeger; 1998 Feb; 160(9):1307-11. PubMed ID: 9495078
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The absence of characteristics lesions in the microcirculation of non-insulin-dependent diabetic patients].
    García Aguilar J; Lerman Garber I; Aranda Frausto A; Posadas Romero C
    Arch Inst Cardiol Mex; 1993; 63(3):209-17. PubMed ID: 8347050
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Anatomopathological findings during development of diabetic cardiomyopathy in rats].
    Manjarrez-Gutiérrez G; Hernández-Chávez V; Neri-Gómez T; Boyzo-Montes de Oca A; Mondragón-Herrera JA; Hernández-Rodríguez J
    Cir Cir; 2014; 82(1):11-9. PubMed ID: 25510787
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The heart and diabetes mellitus].
    Lerman Garber I; Ahumada Ayala M; Posadas Romero C
    Arch Inst Cardiol Mex; 1990; 60(1):79-88. PubMed ID: 2188626
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vascular endothelial dysfunction in diabetic cardiomyopathy: pathogenesis and potential treatment targets.
    Farhangkhoee H; Khan ZA; Kaur H; Xin X; Chen S; Chakrabarti S
    Pharmacol Ther; 2006 Aug; 111(2):384-99. PubMed ID: 16343639
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diabetic cardiomyopathy: mechanisms, diagnosis and treatment.
    Hayat SA; Patel B; Khattar RS; Malik RA
    Clin Sci (Lond); 2004 Dec; 107(6):539-57. PubMed ID: 15341511
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ischemic cardiomyopathy: lack of clinical applicability of the WHO/ISFC classification of cardiomyopathies.
    Boffa GM; Tarantini G; Abbasciano A; Razzolini R; Chioin R; Thiene G
    Ital Heart J; 2001 Oct; 2(10):778-81. PubMed ID: 11721723
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diabetic heart disease--current problems and their management.
    Das AK
    J Assoc Physicians India; 1989 Feb; 37(2):163-5. PubMed ID: 2681139
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diabetic cardiomyopathy: the search for a unifying hypothesis.
    Poornima IG; Parikh P; Shannon RP
    Circ Res; 2006 Mar; 98(5):596-605. PubMed ID: 16543510
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.